Royal DSM, a global purpose-led science-based company, today announces the completion of the sale of its Engineering Materials business to Advent International and LANXESS for an Enterprise Value of €3.85 billion. The agreement was initially announced on 31 May 2022.
The transaction covers all of DSM's Engineering Materials activities and marks the conclusion of DSM's divestment of its Materials businesses in order to focus on Health and Nutrition. DSM anticipates a book profit on the sale of Engineering Materials of around €2.7 billion. DSM will receive approximately €3.5 billion net in cash.
Royal DSM is a global, purpose-led company in Health, Nutrition & Bioscience, applying science to improve the health of people, animals and the planet. DSM's purpose is to create brighter lives for all. DSM's products and solutions address some of the world's biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at www.dsm.com.